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Table. Multivariate analysis of factors associated with 1-year AFS after
PVI (N ¼ 771)
Preoperative characteristic
Hazard
ratio
95% Conﬁdence
interval P value
Dialysis 2.9 2.0-4.2 <.01
Tissue loss 1.8 1.2-2.7 <.01
Dependent living status 1.8 1.1-2.9 .02
Male gender 1.6 1.2-2.1 .01
Congestive heart failure 1.5 1.2-2.0 <.01
Age >80 years 1.4 1.0-1.9 .049
Smoking (prior or current) 0.6 0.5-0.9 <.01
AFS, Amputation-free survival; PVI, peripheral vascular intervention.
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and ilio-femoral PS with a baseline strategy of nonsupervised exercise
(NSE). Estimates for costs and outcomes were obtained from the
medical literature (Table) and the Bureau of Labor Statistics. Costs
were adjusted to 2012 US Dollars. Effectiveness was measured as the
maximum walking distance (MWD) in meters by treadmill testing per-
formed at 1-year. The primary endpoint was cost-effectiveness measured
in dollars per meter walked. Because of a 1-year time horizon, discount-
ing was not used.
Results: The average cost-effectiveness of NSE/SE/PS in dollars per
meter walked was 15.4/19.8/51.6, respectively. When compared with
NSE, the incremental cost-effectiveness ratio for SE was $24.96/m. For
PS, it was $81.1/m. One-way sensitivity analyses (Table, Column 3)
demonstrated that SE was a robust strategy in that it was more cost-effective
than PS in all scenarios. PS was both more costly and less effective (ie, domi-
nated) if MWDPS <207 m or MWDSE >424 m.
Conclusion: When compared with NSE, SE is a more cost-effective
strategy than PS for the treatment of iliofemoral disease in IC.Determinants of Amputation-Free Survival After Peripheral Vascular
Intervention for Critical Limb Ischemia
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Objectives: Our objective was to identify independent predictors
of overall (OS) and amputation-free survival (AFS) in patients under-
going peripheral vascular intervention (PVI) for critical limb ischemia
(CLI).
Methods: We reviewed 1253 patients who underwent 1414 PVI for
CLI within the Vascular Study Group of New England (VSGNE) from
January 2010 to December 2011. A univariate screen of potential predictors
of the primary (AFS) and secondary (OS) end points was performed to
construct a Cox proportional hazards model of survival at 1 year.
Results: All PVI were performed for CLI (rest pain 29%, tissue loss
71%). During each procedure, the number of arteries treated were one
(49%), two (35%), three (12%) and >four (5%). Target arterial segments
and TASC classiﬁcations were aorto-iliac (27%; A 49%, B 25%, C 11%, D
15%), femoral-popliteal (48%; A 30%, B 33%, C 20%, D 17%) and infrapopli-
teal (25%; A 17%, B 15%, C 27%, D 41%). Technical success was high (92%),
while complication rates were low (access site hematoma [5.0%] or occlusion
[0.3%], distal embolization [2.4%]). Mortality and major amputation rates
were 2.8% and 2.2% at 30 days, respectively. Overall percutaneous or open
reintervention rate was 8.0% at 1 year. The Kaplan-Meier estimates of 1-
year OS and AFS were 82% and 76%, respectively. Independent predictors
of AFS included male gender, age>80 years, dependent living status,congestive heart failure, dialysis dependence, and tissue loss; smoking was
protective (Table).
Conclusions: AFS after PVI for CLI is associated with speciﬁc preop-
erative patient characteristics. This data may facilitate efforts to improve
patient selection and, after further validation, enable risk-adjusted outcome
reporting for CLI patients undergoing PVI.Predictors of Increased Length of Stay Following Endovascular AAA
Repair
Virendra I. Patel, Shankha Mukhopadhyay, Mark F. Conrad, David C.
Brewster, Glenn M. LaMuraglia, Michael T. Watkins, Christopher J.
Kwolek, Richard P. Cambria. Massachusetts General Hospital, Boston, Mass
Objectives: Increased length of stay (LOS) following abdominal
aortic aneurysm (AAA) repair increases costs of care and serves as an impor-
tant quality metric. We sought to identify patient and procedural factors
associated with increased postoperative LOS following endovascular aneu-
rysm repair (EVAR).
Methods: All consecutive EVAR patients from a single institution (1/
2010-10/2012) were evaluated for increased LOS, deﬁned as >2 days.
Predictors of increased LOS were identiﬁed by univariate and multivariate
analysis.
Results: We identiﬁed 257 EVAR patients. Increased LOS was
observed in 63% of patients. Univariate analysis showed that patients with
increased LOS were older (78 6 10 vs 73 6 8 years; P < .01), female (27%
vs 14%; P¼ .01), smokers (88% vs 77%; P¼ .03), had coronary artery disease
(35% vs. 18%; P< .01), chronic obstructive pulmonary disease (36% vs 13%; P
< .01), prior AAA repair (11% vs 3%; P¼ .04), elevated creatinine>1.5 mg/
dL (16% vs 7%; P ¼ .05), and larger AAA (59 6 13 mm vs 54 6 8 mm;
P < .01). They were more likely to have general anesthesia (59% vs 44%;
P ¼ .03), longer operating room time (190 6 80 vs 130 6 40 minutes;
P < .01), receive more volume (1960 6 980 vs 1670 6 780 mL; P ¼ .02),
and have higher estimated blood loss (330 6 320 vs 190 6 140 mL; P <
.01). Patients staying >2 days were more likely to require vasopressors (11%
vs 3.4%; P ¼ .05), intensive care unit stay (20% vs 1%; P < .01), and return
to the operating room (5% vs 0%; P ¼ .03). Despite these differences, risk
adjusted independent predictors of increased LOS following EVAR included
symptomatic coronary artery disease (odds ratio [OR] 2.3; 95% conﬁdence
interval [CI], 1.2-4.7; P ¼ .01), chronic obstructive pulmonary disease (OR,
3.4; 95% CI, 1.4-7.9; P < .01), procedure time (per minute; OR, 1.02; 95%
CI, 1.01-1.03; P < .01), age (per year; OR, 1.04; 95% CI, 1.01-1.09; P ¼
.01), while preoperative statin use (OR, 0.29; 95% CI, 0.1-0.6; P < .01),
anddischarge to home (OR,0.07; 95%CI, 0.01-0.48;P< .01)was protective.
Chi-Pi analysis showed that both procedure time (33%) and disposition (26%)
combined accounted for more than half of the increased LOS.
Conclusions: These data highlight clinical and technical variables
associated with increased LOS following EVAR and may be utilized to enact
process improvement measures to improve patient care and reduce hospital
costs.Are Meta-Analyses and Systematic Reviews in Vascular Surgery
Reliable?
Felix J.V. Schlösser, Bauer E. Sumpio. Yale University, New Haven, Conn
Objectives: Meta-analyses (MAs) and systematic reviews (SRs) are
considered the highest level of evidence by the Oxford Centre for Evidence-
Based Medicine. The evidence-based minimum set of “Preferred Reporting
Items for Systematic Reviews andMeta-Analyses” (PRISMA) was introduced
in 2009. The objective of this protocol-driven study was to evaluate the
quality of MAs and SRs published in the Journal of Vascular Surgery.
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Journal of Vascular Surgery between 2010 and 2012, was performed and
included all 27 PRISMA items. For each article, two scores were calculated:
“Points,” where maximally “72” points could be scored per article; and
“Ratio,” where a point fraction could be scored for each PRISMA item.
Results are means 6 standard deviation.
Results: Of 1820 articles totally, 37 were MAs and 18 SRs. From
2010 to 2012, a signiﬁcant decrease in the number of published random-
ized controlled trials and increase in MAs was observed (P ¼ .047),
while SRs remained stable. The average “Points” score for MAs was 45
6 11 and “Ratio” score 17 6 4.7. For SRs, the average “Points”
score was 33 6 11 and “Ratio” score 11 6 3.6. Although statistically
insigniﬁcant, a trend towards improved reporting over time was observed
(P ¼ .271).
Conclusions: As the number of randomized controlled trials in
vascular surgery continues to diminish, the role of SRs and MAs in providing
evidence-based information becomes more important. However, the clarity
and transparency of SRs and MAs are not optimal. Improved conduct and
reporting will be important to advance health care decision-making and
better identify targets for future research.Fig.
Table. Multivariable predictors of ASC complications
Hazard
ratio
95% Conﬁdence
interval P value
Age – – –
<65 years 1.65 0.81-3.33 .167
65-74 years 2.37 1.27-4.42 .006
Preoperative warfarin use 2.46 1.44-4.19 .001
Vascular closure devices vs
manual compression
0.64 0.37-1.13 .124
Post- vs pre-RUS period 0.50 0.29-0.86 .012
ASC, Access-site-related complications; RUS, routine ultrasound-guided.Factors Associated with Femoral Artery Access Site Hematoma
Following Peripheral Vascular Intervention
Jeffrey Kalish,1 Mohammad Eslami,1 James McPhee,1 Christopher Healey,2
Denis Rybin,3 Gheorghe Doros,3 Alik Farber1. 1Boston Medical Center,
Boston, Mass; 2Maine Medical Center, Portland, Me; 3Boston University
School of Public Health, Boston, MassObjectives: Local vascular complications have a reported incidence of
1% to 7% and are the most frequent adverse outcome of femoral arterial
access. This study aimed to identify variables associated with groin hema-
toma after peripheral vascular intervention (PVI).
Methods: The Vascular Study Group of New England (VSGNE)
database (2010-2012) was queried to identify the complication of postpro-
cedural groin hematoma after 4930 PVIs performed via femoral arterial
access. Hematoma (including pseudoaneurysms) was deﬁned as minor
(requiring compression or observation), moderate (requiring transfusion
or thrombin injection), and major (requiring operation). Associated vari-
ables were identiﬁed using multivariable logistic regression models.
Results: The overall post-procedural groin hematoma rate after PVI
was 4.7%, and the rate of moderate/major hematoma was 0.9%. Groin
hematoma had no effect on mortality, but was associated with increased
mean hospital length of stay (3.3 days vs 2 days; P < .001). Independent
predictors of hematoma included: age>80 years (odds ratio [OR] 2.16,
95% CI, 1.04-4.52; P ¼ .04), female gender (OR, 1.81; 95% CI, 1.37-
2.40; P < .001), bilateral femoral access (OR, 1.61; 95% CI, 1.16-2.24;
P ¼ .005), and sheath size >6 French (OR, 1.61; 95% CI, 1.18-2.22;
P ¼ .003). Use of closure devices was protective against hematoma (OR,
0.48; 95% CI, 0.35-0.66; P < .001), as was performance of PVI in the
second half of the academic year (January through June; OR, 0.71; 95%
CI, 0.54-0.93; P < .02). Neither ultrasound guidance nor body mass index
had any effect on hematoma rates.
Conclusions: Many important risk factors that predict hematoma
formation after femoral arterial access for PVI are not modiﬁable. However,
the appropriate use of smaller sheaths as well as closure devices may poten-
tially protect against the complication of hematoma, and may provide
a quality improvement opportunity to decrease patient morbidity as well
as hospital resource utilization.Predictors of Access-Site-Related Complications After Lower Extremity
Percutaneous Revascularization
Ruby C. Lo, Margriet T.M. Fokkema, Thomas Curran, Raul J. Guzman,
Allen D. Hamdan, Mark Wyers, Elliot L. Chaikof, Marc L.
Schermerhorn. Beth Israel Deaconess Medical Center, Boston, Mass
Objectives: Though well described in the cardiology literature, less is
known about risks for access-site-related complications (ASC) following
percutaneous lower extremity revascularization. We also sought to eval-
uate the beneﬁt of routine ultrasound-guided access (RUS) in decreasing
ASC.
Methods: We reviewed all percutaneous revascularizations (percuta-
neous transluminal. angioplasty or stent) performed for lower extremity
atherosclerosis at our institution from 2002 to 2012. RUS began in October
2007. Primary outcome was any ASC (bleeding, groin or retroperitoneal
[RP] hematoma, vessel rupture, or thrombosis). Multivariable logistic
regression was used to determine predictors of ASC.
Results: A total of 1419 punctures were performed on 925 patients
(43% women; median age, 69 years [interquartile range, 60-78 years])
for claudication (30%), critical limb ischemia (58%), or other (12%) using
4- to 8-Fr sheaths. Seventy-six ASC occurred (5.4%): 15 instances of
bleeding, 41 groin and eight RP hematoma, two artery ruptures, nine
pseudoaneurysms, and one thrombosis. Computed tomography evalua-
tion was done in 13, thrombin injection in nine, and operative repair
in 20 patients. ASC were more common before RUS (7.6% vs 4.5%; P
¼ .026). Multivariable predictors of ASC were older age, preoperative
warfarin use, and procedure performance before RUS (Table). Vascular
closure devices were not associated with ASC rates but when
attempted, failures were associated with a higher ASC rate (15% vs 4%;
P ¼ .006).
Conclusions: RUS has decreased ASC in recent years but vascular
closure devices have not demonstrated a signiﬁcant impact. Particular care
